Fig. 3From: Safety of SARS-CoV-2 vaccines: a systematic review and meta-analysis of randomized controlled trialsAdverse reactions to the first dose and second dose of COVID-19 vaccines. †COVID-19 vaccines in the Phase I Trial; ‡COVID-19 vaccines in the Phase II Trial. CI confidence interval, mRNA messenger ribonucleic acidBack to article page